A federal judge has approved a $150 million settlement by GlaxoSmithKline of a 33-member direct purchaser class action over allegations the drugmaker monopolized the market for its nasal spray Flonase.
June 17, 2013 at 12:00 AM
1 minute read
A federal judge has approved a $150 million settlement by GlaxoSmithKline of a 33-member direct purchaser class action over allegations the drugmaker monopolized the market for its nasal spray Flonase.
On Friday, U.S. District Senior Judge Anita B. Brody of the Eastern District of Pennsylvania also approved the payment of $50 million in attorney fees for plaintiffs class counsel.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
